Autolus Therapeutics (AUTL) Return on Sales (2017 - 2025)
Historic Return on Sales for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to 3.73%.
- Autolus Therapeutics' Return on Sales rose 230200.0% to 3.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.4%, marking a year-over-year increase of 223600.0%. This contributed to the annual value of 21.8% for FY2024, which is 1009200.0% up from last year.
- Latest data reveals that Autolus Therapeutics reported Return on Sales of 3.73% as of Q3 2025, which was up 230200.0% from 2.29% recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Return on Sales registered a high of 2.29% during Q2 2025, and its lowest value of 189665254.24% during Q3 2021.
- In the last 5 years, Autolus Therapeutics' Return on Sales had a median value of 30.81% in 2023 and averaged 10005447.54%.
- Per our database at Business Quant, Autolus Therapeutics' Return on Sales plummeted by 2000000000bps in 2021 and then surged by 2000000000bps in 2022.
- Autolus Therapeutics' Return on Sales (Quarter) stood at 166613.59% in 2021, then surged by 100bps to 7.37% in 2022, then plummeted by -1564bps to 122.72% in 2023, then plummeted by -676bps to 951.93% in 2024, then surged by 100bps to 3.73% in 2025.
- Its last three reported values are 3.73% in Q3 2025, 2.29% for Q2 2025, and 7.81% during Q1 2025.